Description
About Ovyrest Forte
Ovyrest Forte combines Cyproterone Acetate 2 mg and Ethinylestradiol 0.035 mg in a tablet formulation positioned as a dedicated management option for androgen excess in women. This combination is clinically documented for its role in managing hyperandrogenism-related conditions in PCOS, offering physicians a targeted therapy rather than a generic hormonal supplement. Beyond hormone management, Ovyrest Forte also functions as an oral contraceptive for women who specifically require anti-androgen therapy, making it a genuinely dual-purpose molecule for gynaecology practice and a meaningful addition to any franchise partner’s women’s health range.
How It Works
Cyproterone Acetate works by inhibiting testosterone activity and suppressing ovarian androgen production, directly addressing the hormonal imbalance behind conditions like hirsutism, acne and androgen-dependent alopecia. Ethinylestradiol complements this by suppressing gonadotrophin secretion, which further supports hormonal regulation while providing reliable contraceptive cover. Published clinical research has shown this combination induces favourable changes in hormone parameters associated with hyperandrogenism in PCOS cases and has demonstrated superiority over metformin specifically in reducing androgen levels, with proven efficacy in managing hirsutism, acne, menstrual abnormalities and alopecia linked to hyperandrogenism.
Indications
- Suppression of ovarian androgens and gonadotrophin secretion
- Inhibits testosterone activity
- Acne, hirsutism and androgen-dependent alopecia
- Oral contraception in women requiring anti-androgen therapy
- Hormonal management associated with PCOS-related hyperandrogenism
Why Source Ovyrest Forte from Lxir
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. A hormonal combination like Cyproterone Acetate and Ethinylestradiol requires exact concentration control to maintain consistent therapeutic and contraceptive reliability across every batch and Ovyrest Forte is manufactured under strict quality protocols to ensure this precision. For a PCD pharma franchise company in India, sourcing a clinically well-documented anti-androgen therapy gives franchise partners a strong, evidence-backed proposition for gynaecologists managing PCOS and hyperandrogenism, supported through our PCD pharma franchise division.
Frequently Asked Questions
Is Ovyrest Forte only used as a contraceptive?
No, while it does provide contraceptive cover, its primary clinical use here is managing androgen excess symptoms such as acne, hirsutism and hair loss.
Is this suitable for women with PCOS?
It is specifically documented for managing hyperandrogenism symptoms associated with PCOS and should be used under medical guidance based on individual evaluation.
How does it compare to metformin for androgen reduction?
Published research has shown this combination to be superior to metformin specifically in reducing androgen levels.
What pack size is available?
Ovyrest Forte is available in a 1 x 21 tablet pack, supplied as 10 x 1 x 21 tablets.
Bulk Order & Manufacturing Enquiry
Pharmaceutical distributors, gynaecology-focused chemists and franchise partners interested in bulk ordering, third-party manufacturing or adding Ovyrest Forte to their women’s health portfolio can connect with Lxir Medilabs through our PCD pharma franchise division for pricing, minimum order details and territory availability across India.
Disclaimer: This is a prescription hormonal product and should be used strictly under the supervision of a registered medical practitioner.
